Drugs / Dihematoporphyrin derivative
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00004430 | Sep 1994 → Sep 1998 | corneal neovascularization | Medical College of Hampton Roads | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dihematoporphyrin derivative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004430 ↗ |
| Known as | DHP | “Demonstrate the safety and efficacy of dihematoporphyrin derivative (DHP) in laser photodynamic therapy (PDT) in patients with corneal neovascularization.” NCT00004430 ↗ |
| Route | Topical | “Patients receive topical dihematoporphyrin derivative (DHP) every 3 hours on days -3 and -2.” NCT00004430 ↗ |